Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals
Javier Arranz‐Nicolás, Jesús Ogando, Denise Soutar, et al.
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 6, pp. 965-980
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Modulating T Cell Responses by Targeting CD3
Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1189-1189
Open Access | Times Cited: 41
Immune Checkpoint Receptors Signaling in T Cells
Gianluca Baldanzi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3529-3529
Open Access | Times Cited: 37
Bioactive Lipids and Their Derivatives in Biomedical Applications
Jin-Won Park, Jaehyun Choi, Dae‐Duk Kim, et al.
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 5, pp. 465-482
Open Access | Times Cited: 35
Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity
Poojitha Sitaram, Bradley Uyemura, Subramaniam Malarkannan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5821-5821
Open Access | Times Cited: 30
Subcellular Localization Relevance and Cancer-Associated Mechanisms of Diacylglycerol Kinases
Antonietta Fazio, Eric Owusu Obeng, Isabella Rusciano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5297-5297
Open Access | Times Cited: 26
DGKA Mediates Resistance to PD-1 Blockade
Lingyi Fu, Sen Li, Weiwei Xiao, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 4, pp. 371-385
Open Access | Times Cited: 23
Diacylglycerol kinase ζ promotes allergic airway inflammation and airway hyperresponsiveness through distinct mechanisms
Brenal Singh, Wen Lu, Amanda M. Schmidt Paustian, et al.
Science Signaling (2019) Vol. 12, Iss. 597
Open Access | Times Cited: 25
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz‐Nicolás, Miguel Martin-Salgado, Irene Adán‐Barrientos, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 11, pp. 3277-3289
Open Access | Times Cited: 18
The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis
Fumio Sakane, Fumi Hoshino, Masayuki Ebina, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5190-5190
Open Access | Times Cited: 18
Potential role of diacylglycerol kinases in immune-mediated diseases
Gianluca Baldanzi, Beatrice Ragnoli, Mario Malerba
Clinical Science (2020) Vol. 134, Iss. 13, pp. 1637-1658
Closed Access | Times Cited: 16
Combination therapy for hepatocellular carcinoma with diacylglycerol kinase alpha inhibition and anti-programmed cell death-1 ligand blockade
Naoki Okada, Ko Sugiyama, Shunsuke Shichi, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 4, pp. 889-903
Open Access | Times Cited: 12
Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors
Isabel Mérida, Javier Arranz‐Nicolás, Pedro Torres‐Ayuso, et al.
Handbook of experimental pharmacology (2019), pp. 133-162
Closed Access | Times Cited: 13
Biological regulation of diacylglycerol kinases in normal and neoplastic tissues: New opportunities for cancer immunotherapy
Javier Arranz‐Nicolás, Isabel Mérida
Advances in Biological Regulation (2019) Vol. 75, pp. 100663-100663
Closed Access | Times Cited: 13
DGK α and ζ Activities Control TH1 and TH17 Cell Differentiation
Jialong Yang, Hongxia Wang, Jinhai Xie, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 10
Identification of ritanserin analogs that display DGK isoform specificity
Mitchell E. Granade, Laryssa Manigat, Michael C. Lemke, et al.
Biochemical Pharmacology (2022) Vol. 197, pp. 114908-114908
Open Access | Times Cited: 6
Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin‐2 production in T cells and induces cell death of melanoma cells
Saki Takao, Rino Akiyama, Fumio Sakane
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 5, pp. 494-506
Closed Access | Times Cited: 8
Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction
Suresh Velnati, Sara Centonze, Giulia Rossino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Diacylglycerol kinases: A look into the future of immunotherapy
Miguel Martin-Salgado, Ane Ochoa-Echeverría, Isabel Mérida
Advances in Biological Regulation (2023) Vol. 91, pp. 100999-100999
Open Access | Times Cited: 3
Ritanserin blocks CaV1.2 channels in rat artery smooth muscles: electrophysiological, functional, and computational studies
Fabio Fusi, Alfonso Trezza, Giampietro Sgaragli, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 9, pp. 1158-1166
Open Access | Times Cited: 8
DGKζ exerts greater control than DGKα over CD8 + T cell activity and tumor inhibition
Junchen Gu, Cindy Wang, Carolyn Cao, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target
Chunshan Liu, Peter Schmezer, Odilia Popanda
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 6
Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1
Suresh Velnati, Sara Centonze, Federico Girivetto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5816-5816
Open Access | Times Cited: 6
Delivering Glioblastoma a Kick—DGKα Inhibition as a Promising Therapeutic Strategy for GBM
Benjamin Purow
Cancers (2022) Vol. 14, Iss. 5, pp. 1269-1269
Open Access | Times Cited: 3
Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases
Yi‐Shi Liu, Zehui Yang, Xiaoman Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13207-13207
Open Access
Page 1 - Next Page

Scroll to top